Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Berger, Thomas (BerichterstatterIn) , Meuer, Stefan (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Journal of neuroimmunology
Year: 2014, Jahrgang: 277, Heft: 1/2, Pages: 145-152
ISSN:1872-8421
DOI:10.1016/j.jneuroim.2014.10.001
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1016/j.jneuroim.2014.10.001
Volltext
Verfasserangaben:Thomas Berger, Christian Jacobi, Judith Haas, Gerhard Ransmayr, Michael Guger, Uwe K. Zettl, Franziska Di Pauli, Birgit Taumberger, Stefan Wietek, Stefan Meuer, Markus Reindl, Thomas Giese

MARC

LEADER 00000caa a2200000 c 4500
001 1504109805
003 DE-627
005 20220812004906.0
007 cr uuu---uuuuu
008 150623s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jneuroim.2014.10.001  |2 doi 
035 |a (DE-627)1504109805 
035 |a (DE-576)434109800 
035 |a (DE-599)BSZ434109800 
035 |a (OCoLC)1340693440 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics  |c Thomas Berger, Christian Jacobi, Judith Haas, Gerhard Ransmayr, Michael Guger, Uwe K. Zettl, Franziska Di Pauli, Birgit Taumberger, Stefan Wietek, Stefan Meuer, Markus Reindl, Thomas Giese 
264 1 |c 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.06.2015 
700 1 |a Berger, Thomas  |d 1964-  |0 (DE-588)132821516  |0 (DE-627)690902417  |0 (DE-576)299436950  |4 oth 
700 1 |a Meuer, Stefan  |d 1951-  |0 (DE-588)1020440198  |0 (DE-627)691221286  |0 (DE-576)360422454  |4 oth 
773 0 8 |i In  |t Journal of neuroimmunology  |d Amsterdam [u.a.] : Elsevier Science, 1981  |g 277(2014), 1/2, Seite 145-152  |h Online-Ressource  |w (DE-627)306659778  |w (DE-600)1500497-1  |w (DE-576)081986408  |x 1872-8421  |7 nnas  |a Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics 
773 1 8 |g volume:277  |g year:2014  |g number:1/2  |g pages:145-152  |g extent:8  |a Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics 
856 4 0 |u http://dx.doi.org/10.1016/j.jneuroim.2014.10.001  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20150623 
993 |a Article 
994 |a 2014 
998 |g 1020440198  |a Meuer, Stefan  |m 1020440198:Meuer, Stefan  |d 910000  |d 911600  |e 910000PM1020440198  |e 911600PM1020440198  |k 0/910000/  |k 1/910000/911600/  |p 10 
999 |a KXP-PPN1504109805  |e 2846850836 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Journal of neuroimmunology","subtitle":"official journal of the International Society for Neuroimmunology","title":"Journal of neuroimmunology"}],"recId":"306659778","language":["eng"],"note":["Gesehen am 19.02.20","Ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomicsJournal of neuroimmunology","part":{"year":"2014","issue":"1/2","pages":"145-152","volume":"277","text":"277(2014), 1/2, Seite 145-152","extent":"8"},"pubHistory":["1.1981 -"],"id":{"issn":["1872-8421"],"eki":["306659778"],"zdb":["1500497-1"]},"origin":[{"dateIssuedKey":"1981","publisher":"Elsevier Science","dateIssuedDisp":"1981-","publisherPlace":"Amsterdam [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Thomas Berger, Christian Jacobi, Judith Haas, Gerhard Ransmayr, Michael Guger, Uwe K. Zettl, Franziska Di Pauli, Birgit Taumberger, Stefan Wietek, Stefan Meuer, Markus Reindl, Thomas Giese"]},"id":{"doi":["10.1016/j.jneuroim.2014.10.001"],"eki":["1504109805"]},"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"recId":"1504109805","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.06.2015"],"person":[{"display":"Berger, Thomas","role":"oth","family":"Berger","given":"Thomas"},{"given":"Stefan","family":"Meuer","role":"oth","display":"Meuer, Stefan"}],"title":[{"title":"Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics","title_sort":"Predicting therapeutic efficacy of intravenous immunoglobulin (IVIG) in individual patients with relapsing remitting multiple sclerosis (RRMS) by functional genomics"}]} 
SRT |a PREDICTING2014